secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001193125-25-120763
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.02, 2.03, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health reduces royalty debt by $1.016M via equity exchanges; Q1 results released
--------------------------------------------------------------------------------

- Issued 60,000 shares to Iliad for $466,200 reduction in October 2020 royalty interest.
- Exchanged all 99.3822 Series J shares for Series L perpetual preferred stock with Streeterville.
- Issued 22 Series L shares to Iliad for $550,000 royalty reduction; Series L pays 0%/10%/15% preferred return.
- Q1 2025 earnings press released (financial details not provided in filing).
- Company will seek stockholder approval to exceed Nasdaq exchange cap for Series L conversions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525120763/0001193125-25-120763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525120763/d63848d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-120763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer